Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study
Authors:
- Remei BlancoRBRemei Blanco
- Josep SoléJSJosep Solé
- Jesús MontesinosJMJesús Montesinos
- Carlos MesíaCMCarlos Mesía
- Manuel AlgaraMAManuel Algara
- Josefa TerrassaJTJosefa Terrassa
- Monserrat GayMGMonserrat Gay
- Monserrat DomenechMDMonserrat Domenech
- Romá BastusRBRomá Bastus
- Isabel BoverIBIsabel Bover
- Miquel NoguéMNMiquel Nogué
- Catalina VadellCVCatalina Vadell
- 1 October 2008
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 62 (1) , 62-71
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyLung Cancer, 2004
- Surgery in locally advanced non-small cell lung cancerLung Cancer, 2003
- Surgery for locally advanced non-small cell lung cancerSeminars in Surgical Oncology, 2003
- Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504Journal of Clinical Oncology, 2003
- Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431Journal of Clinical Oncology, 2002
- Phase I Trial of Weekly Gemcitabine and Concurrent Radiotherapy in Patients With Inoperable Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): a phase I trial for patients with stage III non-small cell lung cancer (NSCLC)European Journal of Cancer, 2001
- Radiosensitization produced in vivo by once- vs. twice-weekly 2′2′-difluoro-2′-deoxycytidine (gemcitabine)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Target volume definition for three-dimensional conformal radiation therapy of lung cancer.British Journal of Radiology, 1998